CORALVILLE, IA / ACCESSWIRE / September 29, 2022 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle ...
Fireside chat with newly appointed CEO, Thijs Spoor, today, February 22 at 1:30 PM ET CORALVILLE, IA / ACCESSWIRE / February 22, 2022 /Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company" ...
RICHLAND, Wash. & CORALVILLE, Iowa--(BUSINESS WIRE)--Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, and Viewpoint Molecular Targeting, Inc., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results